Literature DB >> 19867421

A SARCOMA OF THE FOWL TRANSMISSIBLE BY AN AGENT SEPARABLE FROM THE TUMOR CELLS.

P Rous1.   

Abstract

Entities:  

Year:  1911        PMID： 19867421      PMCID： PMC2124874          DOI： 10.1084/jem.13.4.397

Source DB:  PubMed          Journal:  J Exp Med        ISSN： 0022-1007            Impact factor:   14.307


× No keyword cloud information.
  177 in total

1.  When two is better than one: thoughts on three decades of interaction between Virology and the Journal of Virology.

Authors:  W K Joklik
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

2.  Small-molecule protein tyrosine kinase inhibitors for the treatment of metastatic prostate cancer.

Authors:  Gary E Gallick; Paul G Corn; Amado J Zurita; Sue-Hwa Lin
Journal:  Future Med Chem       Date:  2012-01       Impact factor: 3.808

3.  [Basic problems in cancer research].

Authors:  R DANNEEL
Journal:  Z Krebsforsch       Date:  1953

Review 4.  Comparative pathogenesis of epsilonretroviruses.

Authors:  Donald Holzschu; Lorie A Lapierre; Michael D Lairmore
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

Review 5.  A brief history of melanoma: from mummies to mutations.

Authors:  Vito W Rebecca; Vernon K Sondak; Keiran S M Smalley
Journal:  Melanoma Res       Date:  2012-04       Impact factor: 3.599

Review 6.  Medulloblastoma-biology and microenvironment: a review.

Authors:  Tiara Byrd; Robert G Grossman; Nabil Ahmed
Journal:  Pediatr Hematol Oncol       Date:  2012-06-28       Impact factor: 1.969

7.  Architecture Is the Message: The role of extracellular matrix and 3-D structure in tissue-specific gene expression and breast cancer.

Authors:  Mina J Bissell
Journal:  Pezcoller Found J       Date:  2007-10

8.  Discovery of oncogenes: The advent of molecular cancer research.

Authors:  Klaus Bister
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-07       Impact factor: 11.205

Review 9.  Src signaling pathways in prostate cancer.

Authors:  Andreas Varkaris; Anastasia D Katsiampoura; John C Araujo; Gary E Gallick; Paul G Corn
Journal:  Cancer Metastasis Rev       Date:  2014-09       Impact factor: 9.264

10.  Dasatinib reverses the multidrug resistance of breast cancer MCF-7 cells to doxorubicin by downregulating P-gp expression via inhibiting the activation of ERK signaling pathway.

Authors:  Ting Chen; Changyuan Wang; Qi Liu; Qiang Meng; Huijun Sun; Xiaokui Huo; Pengyuan Sun; Jinyong Peng; Zhihao Liu; Xiaobo Yang; Kexin Liu
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.